Since Namal Nawana took the reigns as Smith & Nephew PLC's CEO last May, he's been laser-focused on growth. Nawana said early on that the British device giant has "excellent technology" across all core segments – orthopedics, sports medicine and wound management – but he saw that less than half of Smith & Nephew's products have been growing at or above market rate.
"Within just the core areas that we operate, we estimate there's a roughly $40bn market growing at around 4%," Nawana...







